Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?
Contreras-Toledo D, Jiménez-Fonseca P, López CL, Montes AF, López Muñoz AM, Vázquez Rivera F, Alonso V, Alcaide J, Salvà F, Covela Rúa M, Guillot M, Martín Carnicero A, Jimeno Mate R, Cameselle García S, Asensio Martínez E, González Astorga B, Fernandez-Diaz AB, González Villaroel P, Virgili Manrique AC, Melián Sosa M, Alonso B, Cousillas Castiñeiras A, Castañón López C, Aparicio J, Carmona-Bayonas A. Contreras-Toledo D, et al. Among authors: virgili manrique ac. Br J Cancer. 2024 Mar;130(5):777-787. doi: 10.1038/s41416-023-02563-w. Epub 2024 Jan 8. Br J Cancer. 2024. PMID: 38191609
Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
Prager GW, Taieb J, Fakih M, Ciardiello F, Van Cutsem E, Elez E, Cruz FM, Wyrwicz L, Stroyakovskiy D, Pápai Z, Poureau PG, Liposits G, Cremolini C, Bondarenko I, Modest DP, Benhadji KA, Amellal N, Leger C, Vidot L, Tabernero J; SUNLIGHT Investigators. Prager GW, et al. N Engl J Med. 2023 May 4;388(18):1657-1667. doi: 10.1056/NEJMoa2214963. N Engl J Med. 2023. PMID: 37133585 Clinical Trial.
Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01).
Aparicio J, Virgili Manrique AC, Capdevila J, Muñoz Boza F, Galván P, Richart P, Oliveres H, Páez D, Hernando J, Serrano S, Vera R, Hernandez-Yagüe X, Gallego RÁ, Riesco-Martinez MC, García de Albeniz X, Maurel J. Aparicio J, et al. Among authors: virgili manrique ac. Clin Transl Oncol. 2022 Nov;24(11):2155-2165. doi: 10.1007/s12094-022-02868-x. Epub 2022 Jun 27. Clin Transl Oncol. 2022. PMID: 35761123 Free PMC article. Clinical Trial.
Brain metastases in colorectal cancer: prognostic factors and survival analysis.
Del Carpio Huerta L, Virgili Manrique AC, Szafranska J, Martin-Richard M, Paez Lopez-Bravo D, Sebio Garcia A, Espinosa Mariscal I, Gomila Pons P, Andres Granyo M, Barba Joaquin A, Barnadas Molins A, Tobeña Puyal M. Del Carpio Huerta L, et al. Among authors: virgili manrique ac. Int J Colorectal Dis. 2018 Nov;33(11):1517-1523. doi: 10.1007/s00384-018-3107-6. Epub 2018 Jun 25. Int J Colorectal Dis. 2018. PMID: 29943356